President Tinubu's administration takes decisive action to revolutionize Nigeria's pharmaceutical sector with new policies aimed at boosting local medicine manufacturing and reducing import dependency.
The Corporate Affairs Commission takes a firm stand against coercion tactics, affirming commitment to lawful operations and regulatory integrity in Nigeria's business landscape.
Major pharmaceutical battle intensifies as Novo Nordisk challenges Pfizer in high-stakes acquisition race for obesity treatment specialist Metsera, reshaping the weight-loss drug market.
British drugmaker GSK raises 2025 profit guidance as Nigeria's tariff reforms create favorable market conditions. Discover how this impacts healthcare costs and medicine availability.
Financial experts reveal how supportive regulators could transform Nigeria's treasury management landscape, driving economic growth and attracting crucial investments.